The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longer follow-up on cardiac safety and distant disease free survival of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab in patients with early-stage HER2-positive breast cancer.
 
Rui Wang
No Relationships to Disclose
 
Anthony Francis Yu
No Relationships to Disclose
 
Richard Steingart
No Relationships to Disclose
 
Sujata Patil
No Relationships to Disclose
 
Jose Baselga
Leadership - Infinity Pharmaceuticals; Varian Medical Systems
Stock and Other Ownership Interests - GRAIL; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma; Varian Medical Systems
Consulting or Advisory Role - Eli Lilly, Novartis; GRAIL
 
Larry Norton
No Relationships to Disclose
 
Cliff Hudis
Consulting or Advisory Role - Genentech/Roche
 
Chau T. Dang
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - Genentech